Cancer drug price caps leave patients still struggling with care costs

Lower maximum retail prices on many cancer medicines have not fully eased the burden for patients in India. Hospitals, diagnostics and supportive care still drive high out-of-pocket spending. Experts say listed-drug caps help, but affordable full treatment remains out of reach for many families facing long therapy courses.